Navigation Links
Gentiva® Health Services to Present at Upcoming Investor Conferences

ATLANTA, March 9, 2011 /PRNewswire/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV) announced today that it will present at the Barclays Capital 2011 Global Healthcare Conference in Miami, Florida at 3:15 p.m. ET on Tuesday, March 15, 2011 and at the Barclays Capital High Yield Bond and Syndicated Loan Conference in Orlando, Florida at 2:05 p.m. ET on Thursday, March 24, 2011.

The presentations will be available to the public via live audio webcasts, which may be accessed by visiting Visitors to this site will also be able to request advance notifications of these or other upcoming Gentiva events.

Gentiva executives will give attendees an overview of Gentiva's operations and strategic priorities, and review opportunities for growth as the United States home health and hospice industries provide more services to an aging population.

About Gentiva Health Services, Inc.Gentiva Health Services, Inc. is the nation's largest provider of home health and hospice services based on revenue, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; and other therapies and services. In August 2010, Gentiva acquired Odyssey HealthCare, Inc., one of the leading providers of hospice care in the United States. GTIV-G

Forward-Looking StatementCertain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: economic and business conditions, including the ability to access capital markets; demographic changes; changes in, or failure to comply with, existing governmental regulations; the impact on our Company of recently passed healthcare reform legislation and its subsequent implementation through governmental regulations; changes in Medicare, Medicaid and commercial payer reimbursement levels; the outcome of any inquiries into the Company's operations and business practices by governmental authorities; the Company's ability to effectively integrate Odyssey's operations; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters, pandemic outbreaks, or terrorist acts; ability to successfully integrate the operations of acquisitions the Company may make and achieve expected synergies and operational efficiencies within expected time-frames; effect on liquidity of the Company's debt service requirements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended January 3, 2010, as supplemented in the Company's quarterly report on Form 10-Q for the third quarter ended October 3, 2010. Financial and Investor Contact:Eric Slusser 770-951-6101eric.slusser@gentiva.comor John Mongelli770-221-6700john.mongelli@gentiva.comMedia Contact:Scott CianciulliBrainerd

SOURCE Gentiva Health Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Gentiva® Health Services to Present at the Oppenheimer and Credit Suisse Healthcare Conferences
2. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
3. Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism
4. Endo to Present at the Barclays Capital 2011 GlobalHealthcare Conference
5. Isis Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
6. CVS/pharmacy Debuts the To Your Health Program in Dallas and Fort Worth Texas, Bringing More Than 80 Free Health Screening Events to the Community
7. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
8. Six Health Plans Pay $1.5 Million in Incentives to Create Medical Homes for Nearly Half a Million Hudson Valley Residents
9. Watson to Present at the Barclays 2011 Global Healthcare Conference
10. BioMarin to Present at the Barclays Global Healthcare Conference
11. Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):